• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

    12/17/24 9:00:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $GRDN alert in real time by email

    Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first venture into New Jersey.

    Founded in 2022 by a group of veteran pharmacists, each with over 35 years of industry experience, Freedom Pharmacy serves more than 1,300 residents. Linda Witzal, RPh, will continue leading the pharmacy in her role as president. All current staff members will continue their employment with Freedom Pharmacy, and the company expects to hire additional employees as it grows its business.

    "This partnership with Guardian Pharmacy Services is a natural fit, allowing us to retain our local focus while leveraging the technology, expertise and resources a national company like Guardian offers," said Witzal. "Having followed Guardian's journey closely, I've appreciated their deep understanding of the complexities of LTC and their commitment to the same values we prioritize in New Jersey---putting residents, patients and staff first. I'm confident this partnership will help us grow and continue providing the exceptional service our communities deserve."

    As part of the Guardian Pharmacy Services family, Freedom Pharmacy benefits from the company's industry-unique business model which ensures the local pharmacy team can focus on customer service to meet the specialized needs of the communities and residents they serve, while Guardian's Corporate Support Team assists with the many complex behind-the-scenes business functions, including data analytics, HR, IT, payor relations, national sales and more.

    "We are proud to partner with Freedom Pharmacy, led by Linda and her team, who have built their reputation and success by always prioritizing the unique needs of the communities and residents they serve," said Fred Burke, president and CEO of Guardian Pharmacy Services. "We are excited to join forces with a trusted local pharmacy that shares our values, enhancing our ability to serve New Jersey residents with the highest level of support and care."

    Founded in 2004, Guardian Pharmacy Services has grown from a single location to 50 pharmacies serving 37 states. This growth has been fueled by a balanced strategy of organic expansion, greenfield startups, and acquisitions, positioning the company for continued success in a rapidly evolving market. For more information, visit www.guardianpharmacy.com.

    About Guardian Pharmacy Services

    Guardian Pharmacy Services is a leading long-term care pharmacy services company that provides an extensive suite of technology-enabled services designed to ensure residents of long-term health care facilities ("LTCFs") are on the appropriate drug regimen and to promote medication adherence, which in turn helps reduce the cost of care and improve clinical outcomes. As of September 30, 2024, our 50 pharmacies served approximately 180,000 residents in approximately 6,800 LTCFs across 37 states.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241218704515/en/

    Get the next $GRDN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GRDN

    DatePrice TargetRatingAnalyst
    10/10/2025$30.00Outperform
    Oppenheimer
    10/21/2024$21.00Outperform
    Raymond James
    10/21/2024$22.00Buy
    Truist
    More analyst ratings

    $GRDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based

    11/10/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference

    Guardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that it will participate in the Stephens Investment Conference in Nashville, TN, on Wednesday, November 19, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat at 11:00 a.m. CT (12:00 p.m. ET) the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for 90 days. About Guardian Pharmacy Services Guardian Pharmacy Services is one of the nation's leading long-term care pharmacy services companies. Through its local

    10/28/25 4:30:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock

    Guardian Pharmacy Services, Inc. (NYSE:GRDN) ("Guardian"), one of the nation's leading long-term care (LTC) pharmacy services companies, today announced that it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC). The registration statement relates to (i) the possible issuance and sale of up to 1,020,000 shares of Class A common stock by Guardian and (ii) the potential resale of up to 4,980,000 outstanding shares of Class A common stock by selling stockholders, in each case from time to time and on a continuous or delayed basis. Guardian recently became eligible to file a Form S-3 registration statement and determined that such filin

    10/14/25 4:47:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cosler Steven D bought $99,786 worth of shares (3,370 units at $29.61), increasing direct ownership by 16% to 24,984 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/5/25 4:10:03 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Cosler Steven D bought $148,540 worth of shares (7,000 units at $21.22), increasing direct ownership by 65% to 17,713 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    11/20/24 4:05:12 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Salentine Thomas J Jr bought $499,996 worth of shares (35,714 units at $14.00) (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    10/1/24 5:48:50 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Forbes Kendall gifted 21,500 shares, decreasing direct ownership by 3% to 790,976 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/8/25 4:10:02 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Officer Burke Fred gifted 200,000 shares, decreasing direct ownership by 12% to 1,511,845 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/8/25 4:10:04 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Cosler Steven D bought $99,786 worth of shares (3,370 units at $29.61), increasing direct ownership by 16% to 24,984 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/5/25 4:10:03 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

    SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/25 2:52:55 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SCHEDULE 13G filed by Guardian Pharmacy Services Inc.

    SCHEDULE 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/12/25 9:33:33 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 10-Q filed by Guardian Pharmacy Services Inc.

    10-Q - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

    11/10/25 4:17:07 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oppenheimer initiated coverage on Guardian Pharmacy Services with a new price target

    Oppenheimer initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $30.00

    10/10/25 8:37:40 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Raymond James initiated coverage on Guardian Pharmacy Services with a new price target

    Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00

    10/21/24 8:25:47 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Truist initiated coverage on Guardian Pharmacy Services with a new price target

    Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00

    10/21/24 7:42:42 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Leadership Updates

    Live Leadership Updates

    View All

    Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

    Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

    5/8/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

    Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent

    12/17/24 9:00:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    12/6/24 12:05:09 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/24 4:30:13 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/24 1:01:24 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Financials

    Live finance-specific insights

    View All

    Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based

    11/10/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call

    Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced today that it will release its third quarter 2025 results on Monday, November 10th, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "11965." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian Pharmacy Services Guardian Pharmacy Services

    10/6/25 8:30:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2025. Second Quarter Financial Results Revenue of $344.3 million, up 15% year-over-year, driven by low double-digit organic growth and acquisitions completed over the past 12 months. Resident count ended the quarter over 195,000, up 12% year-over-year. Net Income of $8.8 million, compared to $15.8 million in the prior-year period. This is not a meaningful comparison primarily due to income tax1 and share-based compensation expenses2 in the recently completed quarter. Adjusted EB

    8/11/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples